Resources to share

We have established a set of the clinical tumor sample-derived models for testing expression and/or physiological function of various genes and signaling pathways. Under collaboration, we are happy to share these samples with other laboratories. See also our collaboration list (link to collaborations/ongoing projects).

1. Patient-derived glioma stem cells
2. Tissue microarray slides with varying grades of glioma and adjacent normal brain tissues


STR Analysis

All published cell lines used and generated by the Nakano laboratory undergo short tandem repeat (STR) analysis as a measure of verifying quality and purity of published cell lines. STR analysis data of our cell lines is freely available here(not yet ready). This data is also available upon request.


IRB Compliance

Patient derived tissues used in our research and cell line generation are collected in compliance with UAB’s Institutional Review Board (IRB) under the approved protocols N151013001 and N151014002.


Institutes that our collaborators belong to (selected, as of June 2015)

National level
MD Anderson Cancer Center
Cincinnati Children’s Hospital
University of South Alabama Mitchell Cancer Institute
Oakwood Healthcare Center – Southgate
Northwestern University, Department of Biomedical Informatics
Cleveland Clinic Lerner Research Institute, Department of Cellular and Molecular Medicine and Department of Stem Cell Biology and Regenerative Medicine
University of Alabama at Birmingham, Neurosurgery and Comprehensive Cancer Center
UCLA School of Medicine, Department of Pharmacology
University of Dayton, Department of Biology
Ohio State University
University of Arizona, Department of Pharmacology & Toxicology
UCSD, Department of Neurosurgery
UC Irvine, Departments of Neurosurgery and Neurology
University of Hawaii Cancer Center, Natural Products and Experimental Therapeutics Program
University of Hawaii Cancer Center, Cancer Biology Program
MGH Simches Research Center and the Broad Institute
Cornell University, Department of Molecular Medicine
University of Virginia School of Medicine, Dept. of Biochemistry and Molecular Genetics
Virginia Tech/Wake Forest University, School of Biomedical Engineering and Sciences
University of Chicago, Comprehensive Cancer Center and Department of Neurology
Columbia University Medical Center, Department of Pathology
University of Texas Austin, Molecular, Cellular and Developmental Biology
Brigham and Women’s Hospital, Harvard Medical School, Neurosurgery

International level
CANADA, McGill University, Pediatrics
UK, The Institute of Cancer Research, Division of Cancer Therapeutics
GERMANY, German Cancer Research Center, Division of Molecular Genetics
FRANCE, Université de Rennes, Institut de Génétique et Développement de Rennes
FRANCE, Institut Albert Bonniot, INSERM
SPAIN, Instituto de Investigaciones Biomédicas August Pi i Sunyer
ITALY, Università di Pisa, Dipartimento di Farmacia
DENMARK, University of Copenhagen, BRIC
JAPAN, National Institute of Advanced Science and Technology
JAPAN, Japanese Foundation for Cancer Research, Division of Molecular Biotherapy Cancer Chemotherapy Center
JAPAN, Keio University, Center for Social Pharmacy and Pharmaceutical Care Sciences
JAPAN, RIKEN Quantitative Biology Center
JAPAN, Osaka University, Research Institute for Microbial Diseases
JAPAN, Kansai Medical College, Neurosurgery
JAPAN, Osaka Medical College, Neurosurgery
JAPAN, Osaka City College, Neurosurgery
S KOREA, Korea University, School of Life Sciences and Biotechnology
S KOREA, National Cancer Center Korea